Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab
European Journal of Cancer · 2025-03 · 219 · 115302
DOI: 10.1016/j.ejca.2025.115302 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025-03. Verfasst von Francesco Cortiula und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology (Maastro), Maastricht University Medical Centre (+), GROW Research Institute for Oncology and Reproduction, Maastric…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Chemoradiotherapy, Antibodies, Monoclonal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology (Maastro), Maastricht University Medical Centre (+), GROW Research Institute for Oncology and Reproduction, Maastricht, the Netherlands; University Hospital of Udine, Department of Oncol…
- Rambam Health Care Campus, Haifa, Israel.
- University Hospitals Seidman Cancer Center, USA; Case Western Reserve University, Cleveland, OH, USA.
- Department of Pulmonary Diseases, Maastricht University Medical Centre (+), GROW Research Institute for Oncology and Reproduction, Maastricht, the Netherlands. Electronic address: https://twitter.com/@HendriksLizza.
- Division of Medical Oncology, Yale Cancer Center, New Haven, CT, USA.
- Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
Zitieren
APA
Cortiula, F., Kutiel, T. S., Hsu, M. L., Hendriks, L. E. L., Nassar, A. H., Moskovitz, M., Kim, S. Y., Mirsky, M. M., Jayakrishnan, R., Bortolot, M., Saddi, J., Borghetti, P., Chung, M. J., Filippi, A. R., De Ruysscher, D., & Bar, J. (2025). Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab. European Journal of Cancer, 219, 115302. https://doi.org/10.1016/j.ejca.2025.115302
Vancouver
Cortiula F, Kutiel TS, Hsu ML, Hendriks LEL, Nassar AH, Moskovitz M, et al. Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab. European Journal of Cancer. 2025;219:115302. doi:10.1016/j.ejca.2025.115302
BibTeX
@article{Cortiula2025,
author = {Cortiula, Francesco and Kutiel, Talia Shentzer and Hsu, Melinda L and Hendriks, Lizza E L and Nassar, Amin H and Moskovitz, Mor and Kim, So Yeon and Mirsky, Matthew M and Jayakrishnan, Ritujith and Bortolot, Martina and Saddi, Jessica and Borghetti, Paolo and Chung, Michelle J and Filippi, Andrea Riccardo and De Ruysscher, Dirk and Bar, Jair},
title = {Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab},
journal = {European Journal of Cancer},
year = {2025},
volume = {219},
pages = {115302},
doi = {10.1016/j.ejca.2025.115302}
}
EUVIMED